ATS: Benralizumab Reduces Glucocorticoid Doses in Asthma

Significant 75 percent reduction in median final oral glucocorticoid doses from baseline
Source: Pulmonary Medicine News - Doctors Lounge - Category: Respiratory Medicine Tags: Internal Medicine, Allergy, Emergency Medicine, Pharmacy, Pulmonology, Conference News, Source Type: news